- Home
- KALV vs RGP Comparison
KALV vs RGP Comparison
Compare KALV & RGP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KALV
- RGP
- Stock Information
- Founded
- KALV N/A
- RGP 1996
- Country
- KALV United States
- RGP United States
- Employees
- KALV N/A
- RGP N/A
- Industry
- KALV Biotechnology: Pharmaceutical Preparations
- RGP Business Services
- Sector
- KALV Health Care
- RGP Consumer Discretionary
- Exchange
- KALV Nasdaq
- RGP Nasdaq
- Market Cap
- KALV 362.2M
- RGP 303.9M
- IPO Year
- KALV N/A
- RGP 2006
- Fundamental
- Price
- KALV $8.75
- RGP $8.69
- Analyst Decision
- KALV Strong Buy
- RGP Hold
- Analyst Count
- KALV 7
- RGP 3
- Target Price
- KALV $27.00
- RGP $13.00
- AVG Volume (30 Days)
- KALV 319.9K
- RGP 453.8K
- Earning Date
- KALV 03-10-2025
- RGP 01-02-2025
- Dividend Yield
- KALV N/A
- RGP 6.56%
- EPS Growth
- KALV N/A
- RGP N/A
- EPS
- KALV N/A
- RGP N/A
- Revenue
- KALV N/A
- RGP $582,058,000.00
- Revenue This Year
- KALV N/A
- RGP N/A
- Revenue Next Year
- KALV N/A
- RGP $16.91
- P/E Ratio
- KALV N/A
- RGP N/A
- Revenue Growth
- KALV N/A
- RGP N/A
- 52 Week Low
- KALV $7.30
- RGP $7.90
- 52 Week High
- KALV $16.88
- RGP $14.29
- Technical
- Relative Strength Index (RSI)
- KALV 51.87
- RGP 55.05
- Support Level
- KALV $7.30
- RGP $8.31
- Resistance Level
- KALV $9.16
- RGP $8.90
- Average True Range (ATR)
- KALV 0.41
- RGP 0.38
- MACD
- KALV 0.07
- RGP 0.00
- Stochastic Oscillator
- KALV 78.17
- RGP 29.05
About KALV KalVista Pharmaceuticals Inc.
KalVista Pharmaceuticals Inc is a pharmaceutical company, which focuses on the discovery, development, and commercialization of small molecule protease inhibitors for a range of diseases. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema and diabetic macular edema; and oral plasma kallikrein inhibitors. Geographically it operates throughout the region of the United States. The company is also conducting preclinical development on a novel, oral, Factor XIIa inhibitor program.
About RGP Resources Connection Inc.
Resources Connection Inc provides consulting and business initiative support services predominantly through its operative subsidiary, Resources Global Professionals. It has two segments RGP ( Resources Global Professionals.) and Sitrick. The RGP segment is focused on delivering consulting services catering to its client's operational needs and change initiatives utilizing a combination of bench and on-demand, talent. The Sitrick segment provides corporate, financial, transactional, and crisis communication and management services. The company generates a majority of its revenue from the RGP segment. Geographically, it derives its key revenue from North America and the rest from Europe and the Asia Pacific region.